Prior research has shown that oncology pharmacists can improve the safety of chemotherapy administration. In this prospective study, researchers found that 129 of 1346 chemotherapy prescriptions issued in a 1-month period at a single university hospital required intervention by an oncology pharmacist. The majority of such interventions were perceived as having a significant impact on patient safety.